Biolegend, 109816, Alexa Fluor® 488 anti-mouse CD45.2 Antibody
100microg
Catalog Number: 109816
Send an RFQ.
Category
| Verified Reactivity | Mouse |
|---|---|
| Antibody Type | Monoclonal |
| Host Species | Mouse |
| Immunogen | B10.S mouse thymocytes and splenocytes |
| Formulation | Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide. |
| Preparation | The antibody was purified by affinity chromatography and conjugated with Alexa Fluor® 488 under optimal conditions. |
| Concentration | 0.5 mg/ml |
| Storage & Handling | The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze. |
| Application | FC - Quality tested |
| Recommended Usage | Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application. * Alexa Fluor® 488 has a maximum emission of 519 nm when it is excited at 488 nm. Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.View full statement regarding label licenses |
| Excitation Laser | Blue Laser (488 nm) |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
| Application Notes |
|---|
| The 104 antibody does not react with mouse cells expressing the CD45.1 alloantigen. Additional reported applications (for the relevant formats) include: immunoprecipitation4, in vivo and in vitro blocking of B cell responses1,2, and immunohistochemical staining of acetone-fixed frozen sections3. |
| Application References(PubMed link indicates BioLegend citation) | Yakura H, et al. 1983. J. Exp. Med. 157:1077. (Block) Yakura H, et al. 1986. J. Immunol. 136:2729. (Block) Suzuki K, et al. 2000. Immunity 13:691. (IHC) Shen FW, et al. 1986. Immunogenetics 24:146. (IP) Baldwin TA and Hogquist KA. 2007. J. Immunol. 179:837. Pascal V, et al. 2007. J. Immunol. 179:1751. Burman AC, et al. 2007. Blood 110:1064. Kincaid EZ, et al. 2007. J. Immunol. 179:3187. Phan TG, et al. 2007. Nature Immunol. 8:992. Nakano-Yokomizo T, et al. 2011. J. Exp Med. 208:1661. PubMed Wen T, et al. 2013. PNAS. 110:6067. PubMed Kohlmeier JE, et al. 2008. Immunity. 29:101. (FC) PubMed |
|---|
| Product Citations | Hirai T, et al. 2020. Immunity. 54(1):84-98.e5. PubMed Özcan A, et al. 2020. J Invest Dermatol. 1003:140. PubMed Peterson EJ, et al. 2019. Mol Syst Biol. 15:e8584. PubMed Li X, et al. 2023. J Clin Invest. 133:. PubMed Read KA, et al. 2023. Nat Commun. 14:1652. PubMed Florian DC, et al. 2023. Cancer Res Commun. 3:223. PubMed Enterina JR, et al. 2022. Cell Rep. 38:110512. PubMed Kuczynski EA, et al. 2022. EMBO Mol Med. 14:e15816. PubMed Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed Wen T, et al. 2013. Proc Natl Acad Sci U S A. 110:6067. PubMed Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed Wang L, et al. 2020. Cells. 0.458333333. PubMed Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed Jing Li et al. 2018. Immunity. 48(4):773-786 . PubMed Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed Sinclair LV et al. 2019. Elife. 8 pii: e44210. PubMed Jonas B, et al. 2016. PLoS One. 11: 0159189. PubMed Inverso D, et al. 2021. Developmental Cell. 56(11):1677-1693.e10. PubMed Tang Q, et al. 2021. Immunity. 54:1961. PubMed Akkaya M, et al. 2020. Sci Rep. 10:13630. PubMed Wang X, et al. 2021. EMBO J. 40:e105926. PubMed Hirasawa M, et al. 2016. J Biol Chem. 291: 7373-7385. PubMed Lever JM, et al. 2019. JCI Insight. 4:e125503. PubMed Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed Zhang F, et al. 2019. Front Immunol. 2.077777778. PubMed Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed |
|---|
| RRID | AB_492869 (BioLegend Cat. No. 109815) AB_492868 (BioLegend Cat. No. 109816) |
|---|
| Structure | Protein tyrosine phosphatase (PTP) family, 180-240 kD |
|---|
| Distribution | All hematopoietic cells except mature erythrocytes and platelets of the CD45.2 strain of mice |
|---|
| Function | Phosphatase, T and B cell activation |
|---|
| Ligand/Receptor | Galectin-1, CD2, CD3, CD4 |
|---|
| Biology Area | Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers |
|---|
| Molecular Family | CD Molecules |
|---|
| Antigen References | 1. Suzuki K, et al. 2000. Immunity 13:691. |
|---|
| Gene ID | 19264 |
|---|
| UniProt | View information about CD45.2 on UniProt.org |
|---|
| Clone | 104 |
|---|
| Regulatory Status | RUO |
|---|
| Other Names | Ly-5.2, LCA |
|---|
| Isotype | Mouse (SJL) IgG2a, κ |
|---|